You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
國家醫保局:對達到八年談判藥納入常規目錄管理 減輕降價壓力
國家醫保局公布《談判藥品續約規則》,對達到八年的談判藥納入常規目錄管理;對未達八年的談判藥,連續協議期達到或超過四年的品種以簡易方式續約或新增適應證觸發降價的,降幅減半。有業內人士認為,規則調整將有利於減輕後期降價壓力。 國家醫療保障局同時公布《非獨家藥品競價規則》,競價結果有效期暫定為兩年。按照該競價規則,醫保方組織測算專家按程序進行測算,提出醫保支付意願作為該通用名藥品的准入門檻。藥品通過競價納入醫保目錄的,取各企業報價中的最低者作為該通用名藥品的支付標準。如企業報價低於醫保支付意願的 70%,以醫保支付意願的70%作為該藥品的支付標準。 競價規則中列明,競價不影響該藥品通用名被納入國家集中帶量採購或政府定價範圍,集中採購中選或政府定價的,按照有關規定確定支付標準。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account